Ceros Financial Services will apply the raise to complete initial clinical trials for its incisionless Duodenal Ilial Bypass anastomosis for bariatric and metabolic surgery.
Ceros Financial Services will apply the raise to complete initial clinical trials for its incisionless Duodenal Ilial Bypass anastomosis for bariatric and metabolic surgery.